205 related articles for article (PubMed ID: 23684702)
1. Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity.
Askenasy N
Autoimmun Rev; 2013 Aug; 12(10):972-5. PubMed ID: 23684702
[TBL] [Abstract][Full Text] [Related]
2. Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation.
Kaminitz A; Yolcu ES; Mizrahi K; Shirwan H; Askenasy N
Int Immunol; 2013 Aug; 25(8):485-94. PubMed ID: 23657001
[TBL] [Abstract][Full Text] [Related]
3. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice.
Kaminitz A; Yolcu ES; Stein J; Yaniv I; Shirwan H; Askenasy N
J Autoimmun; 2011 Aug; 37(1):39-47. PubMed ID: 21497486
[TBL] [Abstract][Full Text] [Related]
4. Treg cells in autoimmunity: from identification to Treg-based therapies.
Göschl L; Scheinecker C; Bonelli M
Semin Immunopathol; 2019 May; 41(3):301-314. PubMed ID: 30953162
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease.
Yolcu ES; Kaminitz A; Mizrahi K; Ash S; Yaniv I; Stein J; Shirwan H; Askenasy N
Exp Hematol; 2013 Oct; 41(10):903-11. PubMed ID: 23743300
[TBL] [Abstract][Full Text] [Related]
6. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
7. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Kasagi S; Zhang P; Che L; Abbatiello B; Maruyama T; Nakatsukasa H; Zanvit P; Jin W; Konkel JE; Chen W
Sci Transl Med; 2014 Jun; 6(241):241ra78. PubMed ID: 24944193
[TBL] [Abstract][Full Text] [Related]
8. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
9. Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells.
Wehrens EJ; Mijnheer G; Duurland CL; Klein M; Meerding J; van Loosdregt J; de Jager W; Sawitzki B; Coffer PJ; Vastert B; Prakken BJ; van Wijk F
Blood; 2011 Sep; 118(13):3538-48. PubMed ID: 21828127
[TBL] [Abstract][Full Text] [Related]
10. The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases.
Zhang A; Qu Y; Zhang B; Zhang L; Zeng C; Peng J; Ji X; Hou M; Zhao Y
J Mol Med (Berl); 2007 Nov; 85(11):1263-70. PubMed ID: 17639287
[TBL] [Abstract][Full Text] [Related]
11. Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion.
Cao T; Wenzel SE; Faubion WA; Harriman G; Li L
Clin Immunol; 2010 Sep; 136(3):329-37. PubMed ID: 20472506
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound Dickkopf-1 in Foxp3
Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based autoimmune disease therapy.
Serra P; Santamaria P
Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
[TBL] [Abstract][Full Text] [Related]
15. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice.
Sharma R; Jarjour WN; Zheng L; Gaskin F; Fu SM; Ju ST
J Autoimmun; 2007 Aug; 29(1):10-9. PubMed ID: 17521882
[TBL] [Abstract][Full Text] [Related]
16. The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.
Miller DC; Whittington KB; Brand DD; Hasty KA; Rosloniec EF
Arthritis Res Ther; 2016 Jan; 18():8. PubMed ID: 26757712
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
[TBL] [Abstract][Full Text] [Related]
18. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
19. FOXP3
Deng B; Zhang W; Zhu Y; Li Y; Li D; Li B
FEBS J; 2022 Jan; 289(2):319-335. PubMed ID: 33529458
[TBL] [Abstract][Full Text] [Related]
20. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
